AriBio Holdings Inc. recorded a single significant purchase by an inside director, Sung Soo Hyeon, who acquired 155,567 shares valued at approximately 505.9 million KRW on September 30, 2026. This transaction occurred amid a 32.5% decline in stock price over the past ninety days, placing the equity near its fifty-two-week low.